Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 7889 - 7896 of 12008 results
I-526 Processing Delays Expected to Continue into 2017
August 2, 2016| Blog| Viewpoint
Massachusetts Legislature Passes Clean Energy Legislation
August 2, 2016| Alert| Viewpoint
States’ Efforts for Drug Price Transparency Stymied by the Pharmaceutical Industry
August 2, 2016| Blog| Viewpoint
California Wrestles with Challenges to Meet the State’s Renewable Energy Goals
August 1, 2016| Blog| Viewpoint
E-Cigarette Makers Contending with New CPSC and FDA Regulations
August 1, 2016| Blog| Viewpoint
OIG Gives Green Light to Hospice Provider’s Payment to Nursing Facilities
August 1, 2016| Blog| Viewpoint
Ninth Circuit Provides Clarification Concerning the Definition of Trade Secret
August 1, 2016| Blog| Viewpoint
FTC Plants A Flag With LabMD Ruling: What This Means for Enforcement
August 1, 2016| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|